Ser507
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.8
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser507  -  TBX21 (human)

Site Information
RRVsPYPsSGDSsSP   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 322212300

In vivo Characterization
Methods used to characterize site in vivo:
flow cytometry ( 1 ) , immunoprecipitation ( 1 ) , mutation of modification site ( 1 ) , western blotting ( 1 )
Disease tissue studied:
leukemia ( 1 ) , T cell leukemia ( 1 )
Relevant cell line - cell type - tissue:
GM03317 ( 1 ) , Jurkat (T lymphocyte) ( 1 ) , MEF (fibroblast) ( 1 ) , MSTO-211H (mesothelial) ( 1 )

Upstream Regulation
Putative in vivo kinases:
RSK2 (human) ( 1 )
Kinases, in vitro:
RSK2 (human) ( 1 )
Treatments:
ionomycin ( 1 ) , phorbol_ester ( 1 )

References 

1

Yao K, et al. (2017) RSK2 phosphorylates T-bet to attenuate colon cancer metastasis and growth. Proc Natl Acad Sci U S A 114, 12791-12796
29133416   Curated Info